TrustuRel 440 mg shown in the provided image contains trastuzumab, a recombinant monoclonal antibody used in HER2-targeted cancer treatment. The pack shown is a 440 mg lyophilized powder for injection from Reliance Life Sciences. Product use and supply should be handled according to the applicable prescription and regulatory requirements in the destination market.
Product Overview
| Product | TrustuRel |
|---|---|
| Active ingredient | Trastuzumab |
| Strength | 440 mg |
| Dosage form | Lyophilized powder for injection |
| Therapeutic area | Oncology |
| Drug class | Monoclonal antibody |
| Target | HER2 |
| Administration | Intravenous infusion under medical supervision |
Uses of Trastuzumab
Trastuzumab is a HER2-targeted therapy. Regulatory product information describes its use in certain HER2-positive breast cancers and HER2-positive metastatic gastric or gastro-oesophageal junction cancers, depending on the specific approved product and market. HER2 status is determined using validated diagnostic testing.
How It Works
Trastuzumab is designed to bind to the HER2 protein on certain cancer cells. This can interfere with HER2 signalling and promote immune-mediated destruction of targeted cells.
Important Safety Considerations
Trastuzumab is a prescription oncology medicine and should be administered only under appropriate medical supervision. Product information highlights the importance of monitoring for reactions associated with infusion and other clinically significant risks. Treatment decisions, dosing, preparation and administration should be determined by qualified healthcare professionals using the approved product information applicable to the patient's country.
International Pharmaceutical Trade
For pharmaceutical exports, requirements can vary considerably between destination countries. Before arranging an international transaction involving trastuzumab, exporters and importers should verify:
- Product registration or applicable regulatory pathway
- Prescription and oncology-medicine requirements
- Import permits and customs documentation
- Manufacturer and batch documentation
- Storage and cold-chain requirements where applicable
- Labeling and packaging requirements
- Importer's authorization/licensing
- Destination-country rules for biological medicines
Availability or regulatory status in one country should not be assumed to establish authorization in another country.
Trading FAQs
Q1. What is TrustuRel 440 mg?
TrustuRel 440 mg is a trastuzumab-containing oncology product presented as lyophilized powder for injection.
Q2. What is trastuzumab used for?
It is used for certain HER2-positive cancers, including specified breast and gastric/GEJ cancers under approved indications.
Q3. Does trastuzumab require HER2 testing?
Yes. Approved trastuzumab treatment for relevant indications requires confirmation of HER2 overexpression or amplification using an appropriate validated assay.
Q4. Is TrustuRel available internationally?
International availability depends on the regulatory authorization, registration and import requirements of each destination country.
Q5. Can TrustuRel be used without a prescription?
Trastuzumab is a prescription oncology medicine and should be used under the supervision of an appropriately qualified healthcare professional.
Q6. Can pharmaceutical buyers request export information?
For legitimate institutional or licensed pharmaceutical trade, buyers can contact the exporter to discuss product documentation, regulatory requirements, packaging and destination-country import procedures.
Why Choose a Professional Pharmaceutical Exporter?
A professional export process should emphasize authentic product documentation, traceability, appropriate packaging, regulatory compliance and transparent communication. For biologic medicines such as trastuzumab, maintaining appropriate handling and documentation throughout the supply chain is particularly important.
Contact MEDINDIA EXPORT
🌐 Website: www.medicineindiaexport.com
📧 Email: sales.medindiaexport@gmail.com
📱 WhatsApp: +91 7218129896
